BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22721615)

  • 21. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
    Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
    Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of FGF-2-induced angiogenesis by scopoletin, a coumarin compound isolated from Erycibe obtusifolia Benth, and its mechanism of action.
    Pan R; Gao X; Lu D; Xu X; Xia Y; Dai Y
    Int Immunopharmacol; 2011 Dec; 11(12):2007-16. PubMed ID: 21896339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
    Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
    Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
    Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
    J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
    Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
    Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
    Pratheeshkumar P; Kuttan G
    Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis.
    Yi EY; Park SY; Song HS; Son MJ; Yi KY; Yoo SE; Kim YJ
    Exp Mol Med; 2006 Oct; 38(5):502-8. PubMed ID: 17079866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic properties of calcium trifluoroacetate.
    Bussolati B; Ribatti D; Munaron L; Bartorelli A; Bussolati G
    Microvasc Res; 2009 Dec; 78(3):272-7. PubMed ID: 19631669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling.
    Kang Y; Regmi SC; Kim MY; Banskota S; Gautam J; Kim DH; Kim JA
    Arch Pharm Res; 2015 Feb; 38(2):249-60. PubMed ID: 25547980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis.
    Moon EJ; Lee YM; Kim KW
    Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.